くすりのしおり

Injection
Revised: 2/2019

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
HERCEPTIN Injection 150
 Active ingredient:
Trastuzumab(genetical recombination)
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine suppresses growth of cancer cells by selectively suppressing the actions of protein named HER2 necessary for growth of cancer cells.
It is usually used to treat breast cancer overexpressing HER2 and advanced or recurrent gastric cancer overexpressing HER2, not amenable to curative resection.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have or have previously experienced heart disease.
    If you have been previously diagnosed with high blood pressure or hypertension.
    If you are having difficulty breathing even at rest or have previously experienced such a symptom.
    If you are treated with radiation therapy.
    If you have previously been treated with anthracycline drugs.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • For breast cancer: In general, administer by intravenous infusion once a day at an interval of once every week or every three weeks.
    For advanced or recurrent gastric cancer, not amenable to curative resection: In general, administer by intravenous infusion once a day at an interval of every three weeks.
  • Dosage and treatment interval depend on the results from checking on the patient's conditions.

Precautions while taking this medicine

  • Since serious cardiac disorder such as cardiac failure may occur, your cardiac function may be checked by echocardiography.
  • If you have a possibility of pregnancy, avoid pregnancy while you are taking this medicine. Also avoid pregnancy for at least seven months after you discontinue this medicine.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include fever, vomiting, chill, nausea, headache, fatigue, nail disorder, loss of appetite, diarrhea, palmar plantar erythema perception deficiency syndrome, stomatitis, hiccup and constipation. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • palpitation, chest pain, decreased blood pressure, slow pulse, irregular heartbeat, fast pulse, cold sweat, cold limbs, dizziness, dizziness on standing up, facial pallor, faint, loss of consciousness, edema, weight increase, fever , dullness, easy fatigability, cough , phlegm , fast breathing, breathing difficulty, shortness of breath, breathing wheezingly, easier breathing at sitting than at lying [cardiac disorder]
  • dizziness, cold sweat, facial pallor, cold limbs, loss of consciousness [shock]
  • itchy body, hives, itching of throat, lightheadedness, breathing difficulty [anaphylaxis]
  • cough, phlegm, shortness of breath, breathing difficulty, fever [interstitial pneumonia, pulmonary disorder]
  • dizziness, ear ringing, headache, chills, sudden high fever, sore throat, nose/gum bleeding, bruise, continuous bleeding, palpitation, shortness of breath, dullness [leukopenia, neutropenia, decreased platelets, anemia]
  • decreased consciousness, yellowness in the skin and/or the white of the eye, itch, dark urine, abdominal bloating, rapid increase in body weight, vomiting of blood, bloody stool (scarlet‾dark red or black stool), dullness, nausea, vomiting, loss of appetite, fever, pain in the upper abdomen, easy fatigability, loss of strength [liver failure, jaundice, hepatitis, liver disorder]
  • decreased urine output, edema dullness [renal disorder]
  • sudden vomiting, dizziness, shivering of limbs, headache, sudden hemiplegia of limbs, sudden difficulty talking, sudden difficulty to utter a word, unresponsiveness to stimulation, decreased consciousness, loss of consciousness, reduced visual acuity, hyperventilation, mental confusion [coma, cerebrovascular disease, brain edema]
  • fever, chills, fast pulse, dullness [sepsis]
  • decreased consciousness, loss of consciousness, decreased urine output, breathing difficulty, shortness of breath [tumor lysis syndrome]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z